Argiromarin
Argiromarin, licence 80030722: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- les Laboratoires Améa Ltée
- NPN or DIN-HM
- 80030722
- Status
- Active licence
- Licence date
- 22 March 2012
- Revision date
- Not provided
- Form
- Pâte
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rosmarinus officinalis Source : Feuille Extraction ratio : 5.0:1.0 Dry plant equivalent : 50.0 g | 10.0 g | Not calculated |
Non-medicinal ingredients
Illite, Alcool benzylique, Acide Déshydroacétique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Utilisé traditionnellement en phytothérapie pour aider à contribuer au maintien la circulation périphérique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si les symptômes s'aggravent. Consulter un praticien de soins de santé si les symptômes persistent. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez. Consulter un praticien de soins de santé avant d'en faire l'usage si vous avez de larges plaies ouvertes ou des lésions cutanées, de la fièvre, de l'inflammation aigüe ou si vous souffrez de troubles circulatoires importants ou d'hypertension.
- Effets indésirables connus
Une hypersensibilité peut se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80030722
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.